FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

34550211000001107: Tardiben 25mg tablets (AOP Orphan Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Jun 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1538501000001115 Tardiben 25mg tablets (AOP Orphan Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1538521000001110 Tardiben 25mg tablets (AOP Orphan Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
104546701000001110 Tardiben 25mg tablets (AOP Orphan Pharmaceuticals AG) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
104546801000001118 Tardiben 25mg tablets (AOP Orphan Pharmaceuticals AG) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tardiben 25mg tablets (AOP Orphan Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tardiben 25mg tablets (AOP Orphan Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tardiben 25mg tablets (AOP Orphan Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tardiben 25mg tablets (AOP Orphan Ltd) Is a Product containing precisely tetrabenazine 25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Tardiben 25mg tablets (AOP Orphan Ltd) Has active ingredient Tetrabenazine false Inferred relationship Existential restriction modifier
Tardiben 25mg tablets (AOP Orphan Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Tardiben 25mg tablets (AOP Orphan Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tardiben 25mg tablets (AOP Orphan Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tardiben 25mg tablets (AOP Orphan Ltd) Has specific active ingredient Tetrabenazine true Inferred relationship Existential restriction modifier
Tardiben 25mg tablets (AOP Orphan Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tardiben 25mg tablets (AOP Orphan Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Tardiben 25mg tablets (AOP Orphan Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tardiben 25mg tablets (AOP Orphan Ltd) Is a Tardiben true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tardiben 25mg tablets (AOP Orphan Ltd) 112 tablet Has AMP True Tardiben 25mg tablets (AOP Orphan Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start